Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harvey Pass

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2013
Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancerRaja Flores, Thomas Bauer, Ralph Aye, et al.
The Annals of Thoracic Surgery|October 24, 2024
Characteristics of Long-term Survivors With Malignant Pleural MesotheliomaIsabelle Opitz, Olivia Lauk, Raphael Werner, et al.
Annals of Surgery|May 28, 2016
Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid NodulesRaja M Flores, Daniel Nicastri, Thomas Bauer, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Characterization of tumor heterogeneity through segmentation-free representation learningJimin Tan, Hortense Le, Jiehui Deng, et al.
The New England Journal of Medicine|February 13, 2023
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung CancerNasser Altorki, Xiaofei Wang, David Kozono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancerNasser Altorki, Maureen E Lane, Thomas Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2021
Genomic Profiling of Lung Adenocarcinoma in Never-SmokersSiddhartha Devarakonda, Yize Li, Fernanda Martins Rodrigues, et al.
Cancer Research|November 30, 2018
A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CTAndrew V Kossenkov, Rehman Qureshi, Noor B Dawany, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibJames Bean, Cameron Brennan, Jin-Yuan Shih, et al.
Science Translational Medicine|October 18, 2013
A blood-based proteomic classifier for the molecular characterization of pulmonary nodulesXiao-jun Li, Clive Hayward, Pui-Yee Fong, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2013
Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancerRaja Flores, Thomas Bauer, Ralph Aye, et al.
The Annals of Thoracic Surgery|October 24, 2024
Characteristics of Long-term Survivors With Malignant Pleural MesotheliomaIsabelle Opitz, Olivia Lauk, Raphael Werner, et al.
Annals of Surgery|May 28, 2016
Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid NodulesRaja M Flores, Daniel Nicastri, Thomas Bauer, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Characterization of tumor heterogeneity through segmentation-free representation learningJimin Tan, Hortense Le, Jiehui Deng, et al.
The New England Journal of Medicine|February 13, 2023
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung CancerNasser Altorki, Xiaofei Wang, David Kozono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancerNasser Altorki, Maureen E Lane, Thomas Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2021
Genomic Profiling of Lung Adenocarcinoma in Never-SmokersSiddhartha Devarakonda, Yize Li, Fernanda Martins Rodrigues, et al.
Cancer Research|November 30, 2018
A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CTAndrew V Kossenkov, Rehman Qureshi, Noor B Dawany, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibJames Bean, Cameron Brennan, Jin-Yuan Shih, et al.
Science Translational Medicine|October 18, 2013
A blood-based proteomic classifier for the molecular characterization of pulmonary nodulesXiao-jun Li, Clive Hayward, Pui-Yee Fong, et al.
Pageof 9